Analysis of Interwoven Nitinol Stenting for the Treatment of Critical Limb Ischemia: Outcomes From an Average 3-Year Follow-up Period

被引：6

作者：

Krishnan, Prakash ^{[1
,2
]}

Tarricone, Arthur ^{[1
,2
]}

Gee, Allen ^{[1
,2
]}

Farhan, Serdar ^{[1
,2
]}

Kamran, Haroon ^{[1
,2
]}

Kapur, Vishal ^{[1
,2
]}

Gujja, Karthik ^{[1
,2
]}

Kini, Annapoorna ^{[1
,2
]}

Sharma, Samin ^{[1
,2
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Med Cardiol, Zena & Michael A Weiner Cardiovasc Inst, Icahn Sch Med,Mt Sinai Hosp, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Marie Josee & Henry R Kravis Cardiovasc Hlth Ctr, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA

来源：

ANGIOLOGY | 2022年 / 73卷 / 05期

关键词：

Supera stent; critical limb-threatening ischemia; peripheral artery disease; atherectomy; percutaneous transluminal angioplasty; lower extremity; SUPERFICIAL FEMORAL-ARTERY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ENDOVASCULAR TREATMENT; BALLOON ANGIOPLASTY; PROXIMAL POPLITEAL; UNITED-STATES; DISEASE; IMPLANTATION; LESIONS; BURDEN;

D O I：

10.1177/00033197211043406

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

We assessed the clinical outcomes of patients with critical limb-threatening ischemia (CLTI) who underwent interwoven nitinol stent (Supera) implantation for significant stenoses of the femoropopliteal segment. In this retrospective cohort study, 116 consecutive patients with CLTI who were treated with Supera stents between September 2015 and March 2020 were included in this analysis. Primary endpoint analysis was completed for amputation-free survival, target lesion revascularization (TLR), and mortality. After a mean follow-up time of 3.4 years, 21 (18%) patients had undergone amputations, 3 (2.6%) died, and, overall, the amputation-free survival rate was 81%. TLR occurred in 21 (18%) patients, resulting in the freedom from target lesion revascularization of 82%. The average Wagner score for all patients was 2.8 +/- 1.1. A subgroup analysis of 57 patients revealed a median ulcer size of 3.0 cm(2) [1.65, 9.0], with complete healing for 45 patients by 20 months. The Wagner score of this subgroup decreased by an average of 3.4 +/- .9 points. Supera stents can be used together with other endovascular therapies and are a safe and effective treatment modality for CLTI.

引用

页码：407 / 412

页数：6

共 35 条

[1] The natural history of untreated severe or critical limb ischemia [J].

Abu Dabrh, Abd Moain ;

Steffen, Mark W. ;

Undavalli, Chaitanya ;

Asi, Noor ;

Wang, Zhen ;

Elamin, Mohamed B. ;

Conte, Michael S. ;

Murad, Mohammad Hassan .

JOURNAL OF VASCULAR SURGERY, 2015, 62 (06) :1642-+

[2] Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry [J].

Armstrong, Ehrin J. ;

Jeon-Slaughter, Haekyung ;

Kahlon, Ravi S. ;

Niazi, Khusrow A. ;

Shammas, Nicolas W. ;

Banerjee, Subhash .

JOURNAL OF ENDOVASCULAR THERAPY, 2020, 27 (01) :60-65

[3] Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence [J].

Bishu, Kalkidan ;

Armstrong, Ehrin J. .

VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 :387-395

[4] Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial [J].

Bradbury, AW ;

Ruckley, CV ;

Fowkes, FGR ;

Forbes, JF ;

Gillespie, I ;

Adam, DJ ;

Beard, JD ;

Cleveland, T ;

Bell, J ;

Raab, G ;

Storkey, H .

LANCET, 2005, 366 (9501) :1925-1934

[5] The burden of critical limb ischemia: a review of recent literature [J].

Duff, Steve ;

Mafilios, Michael S. ;

Bhounsule, Prajakta ;

Hasegawa, James T. .

VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 :187-208

[6]

Dumantepe M., 2015, VASCULAR, V25, P666

[7] Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries Twelve-Month Results of the SUPERB Trial [J].

Garcia, Lawrence ;

Jaff, Michael R. ;

Metzger, Christopher ;

Sedillo, Gino ;

Pershad, Ashish ;

Zidar, Frank ;

Patlola, Raghotham ;

Wilkins, Robert G. ;

Espinoza, Andrey ;

Iskander, Ayman ;

Khammar, George S. ;

Khatib, Yazan ;

Beasley, Robert ;

Makam, Satyaprakash ;

Kovach, Richard ;

Kamat, Suraj ;

Leon, Luis R., Jr. ;

Eaves, William Britton ;

Popma, Jeffrey J. ;

Mauri, Laura ;

Donohoe, Dennis ;

Base, Carol C. ;

Rosenfield, Kenneth .

CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (05)

[8] SUPERB Final 3-Year Outcomes Using Interwoven Nitinol Biomimetic Supera Stent [J].

Garcia, Lawrence A. ;

Rosenfield, Kenneth R. ;

Metzger, Christopher D. ;

Zidar, Frank ;

Pershad, Ashish ;

Popma, Jeffrey J. ;

Zaugg, Margo ;

Jaff, Michael R. .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 (07) :1259-1267

[9] Endovascular Treatment of Popliteal Artery Segments P1 and P2 in Patients With Critical Limb Ischemia: Initial Experience Using a Helical Nitinol Stent With Increased Radial Force [J].

Goltz, Jan P. ;

Ritter, Christian O. ;

Kellersmann, Richard ;

Klein, Detlef ;

Hahn, Dietbert ;

Kickuth, Ralph .

JOURNAL OF ENDOVASCULAR THERAPY, 2012, 19 (03) :450-456

[10] National health care costs of peripheral arterial disease in the Medicare population [J].

Hirsch, Alan T. ;

Hartman, Lacey ;

Town, Robert J. ;

Virnig, Beth A. .

VASCULAR MEDICINE, 2008, 13 (03) :209-215

← 1 2 3 4 →